46 completed, 17 unknown, 8 recruiting, 7 terminated. 83 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 83 | Completed 46, Unknown 17, Recruiting 8, Terminated 7, Withdrawn 4, Active not recruiting 1 |
| Phase 2 | 9 | Completed 5, Unknown 3, Terminated 1 |
Follow Ticagrelor: new trials by email Literature Review of Ticagrelor trials Research Report on Ticagrelor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. Clopidogrel, Ticagrelor, Prasugrel - Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 3 | Recruiting | Cardiocentro Ticino | 355 | 2026-04-20 | 2026-05-13 |
| Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone Ticagrelor + placebo, Ticagrelor + aspirin - NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI) | Phase 3 | Recruiting | Montreal Heart Institute | 2570 | 2026-03-03 | 2026-03-10 |
| Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA Ticagrelor 90 MG, Clopidogrel, Aspirin 75 Mg Oral Tablet - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 900 | 2024-09-01 | 2025-09-05 |
| Ticagrelor Versus Cilostazol in Ischemic Stroke Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 900 | 2024-08-30 | 2024-08-20 |
| One-Month DAPT in CABG Patients Ticagrelor 90 MG, Low-dose aspirin - Chronic Coronary Disease | Phase 3 | Recruiting | Weill Medical College of Cornell University | 700 | 2024-08-15 | 2025-12-22 |
| Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA Ticagrelor 90 MG, Cilostazol 100 MG, Aspirin 75mg - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 900 | 2024-08-10 | 2025-09-18 |
| Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke Early Dual Antiplatelet Therapy, Placebo - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 1382 | 2024-04-03 | 2026-01-22 |
| Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 580 | 2024-03-30 | 2024-08-20 |
| TADCLOT- a Double Blind Randomized Controlled Trial Ticagrelor 90 MG, Clopidogrel - Stent Thrombosis, Myocardial Infarction, Acute | Phase 3 | Completed | National Institute of Cardiovascular Diseases, Pakistan | 2200 | 2024-02-19 | 2025-07-10 |
| Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 900 | 2023-12-01 | 2024-08-20 |
| Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg - Stroke, Stroke, Ischemic | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 2800 | 2023-05-17 | 2025-09-08 |
| Ticagrelor Versus Clopidogrel in Ischemic Stroke Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet - Ischemic Stroke | Phase 3 | Completed | Kafrelsheikh University | 900 | 2022-10-01 | 2024-05-14 |
| Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis Ticagrelor + Aspirin, Rivaroxaban + Aspirin, Clopidogrel + Aspirin - Intracranial Arteriosclerosis, Stroke | Phase 3 | Active not recruiting | University of Florida | 1683 | 2022-08-02 | 2026-11-02 |
| Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA Ticagrelor 90 MG, Clopidogrel - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 900 | 2022-05-01 | 2024-09-19 |
| Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 900 | 2022-02-09 | 2024-09-19 |
| Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Ticagrelor 90mg, Ticagrelor 60mg, Aspirin - STEMI, NSTEMI | Phase 3 | Unknown | Collegium Medicum w Bydgoszczy | 4500 | 2022-02-07 | 2023-04-21 |
| Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence Ticagrelor 90mg (Brilique), Ticagrelor 90mg (Ticaloguard) - Cardiovascular Diseases, Acute Coronary Syndrome | Phase 3 | Completed | Cairo University | 29 | 2021-11-13 | 2022-07-26 |
| Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke Ticagrelor 90 MG, Clopidogrel - Ischemic Stroke | Phase 3 | Completed | Kafrelsheikh University | 580 | 2021-09-01 | 2023-12-29 |
| Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Completed | Mazandaran University of Medical Sciences | 90 | 2021-08-08 | 2023-10-19 |
| Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT) Ticagrelor Oral Tablet [Brilinta], Low molecular weight heparin - Hepatic Artery Thrombosis, Liver Transplant; Complications | Phase 3 | Unknown | RenJi Hospital | 50 | 2021-07-31 | 2021-07-01 |
Showing 20 of 83. Sign in to see all of them.
Coronary Artery Disease (19) · Acute Coronary Syndrome (16) · Ischemic Stroke (14) · Myocardial Infarction (11) · ST Elevation Myocardial Infarction (8) · Stroke (7) · Ischemic Attack, Transient (5) · Atrial Fibrillation (4) · Peripheral Arterial Disease (4) · Renal Insufficiency, Chronic (4) · Angina, Stable (3) · Angina, Unstable (3) · Cardiovascular Diseases (3) · Diabetes Mellitus (3) · Kidney Failure, Chronic (3)
AstraZeneca (10) · Kafrelsheikh University (10) · First Affiliated Hospital of Harbin Medical University (4) · Beijing Tiantan Hospital (3) · Dong-A University (3) · Kyunghee University Medical Center (3) · Ottawa Heart Institute Research Corporation (3) · University of Patras (3) · Assistance Publique - Hôpitaux de Paris (2) · Collegium Medicum w Bydgoszczy (2) · Assistance Publique Hopitaux De Marseille (1) · Assiut University (1) · Boehringer Ingelheim (1) · Cairo University (1) · Campus Bio-Medico University (1)
Canada (18) · United States (18) · China (17) · South Korea (17) · France (16) · Italy (15) · Germany (13) · Egypt (12) · Poland (12) · Belgium (11) · Brazil (11) · Spain (11) · United Kingdom (11) · Australia (10) · Hungary (10)
Anders Berggren, MD, PhD (2) · Judith Hsia, MD (2) · Moo Hyun Kim, M.D. (2) · Weon Kim, MD, PhD (2) · Abdul Hakeem (1) · Ahmed I Elbassiouny, MD (1) · Alexander Parkhomenko, MD,PhD (1) · Andreas Gotte, Prof., MD (1) · Asim Cheema, MD (1) · Athena Sharifi-Razavi (1) · Brian L. Hoh, MD, MBA (1) · Carlos Tajer, MD,PhD (1) · Christopher Granger, MD,PhD (1)
PMID 35224730, PMID 31867054, PMID 2375765, PMID 27160944, PMID 18190818, PMID 34515113, PMID 16731270, PMID 19717846, PMID 27160892, PMID 29915123, PMID 30015064, PMID 11914403, PMID 12807523, PMID 15738352, PMID 16260639, PMID 17637939, PMID 19324253, PMID 19761935, PMID 20079528, PMID 20194878, PMID 20594935, PMID 20805430, PMID 21060072, PMID 21545948, PMID 21685437, PMID 21709065, PMID 22090660, PMID 22179530, PMID 22261200, PMID 22546885, PMID 22572911, PMID 22719022, PMID 22789884, PMID 22980299, PMID 22991347, PMID 23021325, PMID 23137503, PMID 23277305, PMID 23373620, PMID 23572474, PMID 23800556, PMID 23866179, PMID 23900047, PMID 24016496, PMID 24170388, PMID 24561148, PMID 24655690, PMID 24682844, PMID 24830710, PMID 24952862
2014 (2), 2015 (2), 2016 (2), 2023 (2), 2009 (1), 2017 (1), 2019 (1), U01NS117450 (1)